Table 1 Characteristics of patients with ovarian cancer who underwent cholecystectomy during the course of the disease (n = 62)
From: Significance of cholecystectomy in cytoreductive surgery for advanced ovarian cancer
Age (years) | 52 (24–78) |
Initial FIGO stage | |
I | 3 (4.8%) |
II | 0 (0%) |
III | 43 (69.4%) |
IV | 16 (25.8%) |
Time of the cholecystectomy | |
Primary debulking surgery | 32 (51.6%) |
Interval debulking surgery | 16 (25.8%) |
Secondary debulking surgery | 9 (14.5%) |
Follow-up (only cholecystectomy) | 5 (8.1%) |
Final pathology | |
No lesion (no infiltration group) | 32 (51.6%) |
Cancer invasion | 18 (29.0%) |
Chronic cholecystitis | 12 (19.4%) |
Complication after cholecystectomy | |
GB bed bleeding | 1 (1.6%) |
Drain placement in 30 days | 1 (1.6%) |
Readmission in 30 days | 0 (0.0%) |
Time to chemotherapy (days) | 22 (18–51) |
Residual disease after primary surgery | |
NGR | 45 (72.6%) |
GR-1 | 16 (25.8%) |
GR-B | 1 (1.6%) |
Follow-up duration, month | 18 (2–107) |